British taxpayer{And US) money is being painfully wasted on

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
258
British taxpayer{And US) money is being painfully wasted on hopeless strategies

https://finance.yahoo.com/news/british-taxpay...00098.html

President Biden has sunk $52 (£42bn) billion of subsidies into the industry, while protecting it with a wall of trade and tariff barriers. The European Union has mobilised $43 billion in financial support to secure production, on top of which major member states such as France and Germany are spending more.

Even in the UK, the Chancellor has been hunting down the back of the sofa to see if he can find a billion or two for the British industry. Over the last year, major global economies have been pouring billions into subsidising microchip manufacturing.

The tiny transistors on silicon chips that power modern technology, from computers to satellites or weapons, have been described as the “new oil”. We can all understand that this resource, critical to the electronic devices required in a modern economy, is extremely important. And we will need a lot more chips in the future.

Yet last week, Samsung revealed its profits were falling on weak chip demand. This week, Taiwan’s TSMC, the semiconductor manufacturing firm, reported shrinking order books. Device sales have been slowing since late-2022, inventory has recovered, and chip levels have approached normal.

Which means that we are facing massive spare capacity in the coming years. In reality, the micro-glut will expose the folly of industrial strategy all over again – with tens of billions of taxpayer money painfully wasted in the process.

Over the last couple of years, every government in the world has been worrying about how to increase production of micro-processors. Last year, President Biden signed into law the $280 billion Chips and Science Act, with around $52 billion committed towards microchip production.

In an unprecedented step, Biden banned US companies from supplying chips to Chinese companies. To compete, the EU launched its own Chips Act, mobilising more than $40 billion for a mixture of direct handouts to manufacturers and tax breaks. EU executives have been courting the microchip industry’s big three – Intel, Samsung and TSMC, to up Europe’s market share in global semiconductors to 20 per cent by 2030.

And the UK has its own microchip strategy, although so far it mostly consists of a “consultation study” launched in December, along with some vague noises about blocking the sale of our largest manufacturer, Newport Wafer Fab. To listen to the grand speeches made as each fresh multi-billion package of subsidies was unveiled the message was clear: there is a catastrophic lack of microchips, and if countries don’t generate their own supplies then economies will grind to a halt. Only a state-led industrial strategy can resolve these potentially catastrophic shortages.

Yet, as mentioned, Samsung last week reported that profits had dived by 90pc, and announced it would be cutting production of memory processors, largely because there were too many on the market. TSMC has missed earnings estimates on weak sales of its processors, while overall chip production in Taiwan is expected to be down by 5.6pc this year.

Meanwhile, last month Intel asked the German government to come up with another $5 billion in subsidies to help it complete a plant in the country, hardly a sign of a project that is economically viable. Add it all up, and a picture starts to emerge of an industry with too much production, rather than too little.

It is not hard to work out why. Global demand is slowing as interest rates rise and demand cools. The tech industry is reportedly cutting back on staff and new product launches, while sales of products such as electric vehicles, huge consumers of microchips, have started to decelerate. During the pandemic, there were shortages as supply chains snarled up, and demand for electronic devices surged, but that massive disruption has calmed. The cycle is turning.

Of course, we can all understand why governments might want to boost domestic production. The world is critically dependent on Taiwanese chip factories – the island accounts for 65pc of global output – and Beijing moves on Taipei, then we will be glad for having diversified our supply chains.

Likewise, relying on Chinese factories may prove risky, though China itself is the second largest importer of semiconductor devices in the world. There is a case to be made for putting together a back-up plan for domestic production in case of a major conflict.

But creating a new, mass market manufacturing capacity from scratch? That is already starting to look like a very expensive mistake. Over the next few years, all those heavily subsidised plants in the United States, Germany and France are going to come on stream, selling chips into a global market where there are too many of them, and prices are tumbling. The losses could be vast. Taxpayer money will have been put to terrible use and, in the UK, Treasury officials will
perhaps be quietly breathing a sigh of relief that we were too hopelessly disorganised to launch our own strategy.

There is a lesson to be taken from the microchip experience, not least at a time when “industrial strategies” are more popular than ever. Just because a product is important, it does not mean any particular country has to produce it. And if demand is growing, as it has been for microchips, it is safe to assume that private companies will be capable of meeting that need without any help from the state.

Too often, governments end up subsidising the wrong industries at the wrong time. They have a poor record of picking winners, and should instead set low and fair taxes, lower tariffs, keep competition open, and break-up any cartels. Once they have done all that, the market can decide which are the industries of the future.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

U Power Limited Advances Electric Vehicle Solutions in Europe

Updated Category News Views 239

U Power Limited Expands Its European Reach U Power Limited (Nasdaq: UCAR) is making significant strides in the electric vehicle (EV) landscape. The company, known for its innovative battery-swapping technology, has announced an exciting joint venture that enhances their presence in the European market. This strategic move is expected to reshape how electric mobility is...

Continue Reading
UKG Stands Out as a Top Leader in Workforce Management Solutions

Updated Category News Views 163

UKG Secures Top Spot in Workforce Management UKG, a leading provider in HR, payroll, workforce management, and cultural solutions, has recently earned recognition for its exceptional contributions to the workforce management field. The company has been named a Leader in the NelsonHall New World Workforce Management 2024 evaluation, showcasing its strong performance across...

Continue Reading
Prominent Movers in Today's Market: Micron, Accenture Rise

Updated Category News Views 141

As the trading day unfolds, the US stock market is witnessing a shift, with several companies experiencing significant movements in their stock prices. Recent trends show that investors are closely monitoring the market after a minor disruption in gains. Micron's Robust Performance Micron Technology (NASDAQ: MU) has captured the spotlight today, with shares surging by an...

Continue Reading
Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events

Updated Category News Views 85

Celebrating 1.5 Years of Obey Me! Nightbringer Obey Me! Nightbringer is reaching a significant milestone, celebrating its 1.5-year anniversary. This beloved mobile game from NTT Solmare has captured the hearts of players around the globe, and to acknowledge this momentous occasion, the developers are rolling out a variety of exciting events. Four Exciting Events for...

Continue Reading
Celebrating Innovation: 2026 sofi™ Awards Winners Unveiled

Updated Category News Views 219

Celebrating Culinary Excellence: The 2026 sofi™ Awards NEW YORK — The Specialty Food Association (SFA) revealed the much-anticipated results of the 2026 sofi™ Awards at the Winter FancyFaire event. This celebrated gathering brought together industry leaders, chefs, makers, and buyers to applaud the finest in specialty food and beverage innovation. A Night of...

Continue Reading